Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00104078 |
Date of registration:
|
22/02/2005 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Study Evaluating MYO-029 in Adult Muscular Dystrophy
|
Scientific title:
|
|
Date of first enrolment:
|
February 2005 |
Target sample size:
|
108 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00104078 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
Phase:
|
Phase 1/Phase 2
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
Medical Monitor, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Wyeth is now a wholly owned subsidiary of Pfizer |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Written informed consent.
- Confirmed clinical and molecular diagnosis of Becker Muscular Dystrophy (BMD),
Facioscapulohumeral Muscular Dystrophy (FSHD), or Limb-Girdle Muscular Dystrophy
(LGMD)
- Independently ambulatory
Exclusion Criteria:
- Patients with certain clinical conditions
- Patients using steroids or other medications with the potential to affect muscle
function
- History of sensitivity to monoclonal antibodies or protein pharmaceuticals
- Pregnant or lactating women.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Facioscapulohumeral Muscular Dystrophy
|
Becker Muscular Dystrophy
|
Limb-Girdle Muscular Dystrophy
|
Intervention(s)
|
Drug: MYO-029
|
Primary Outcome(s)
|
Safety assessment
|
Secondary ID(s)
|
3147K2-101
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|